Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 471

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 9A
Chunk 471
---
 this amount, $72.9 million related to options with service conditions only, $7.9 million related to PSUs with certain performance conditions not met and the remaining $157.7 million related to restricted stock units with service conditions only.

16. 401(K) PLANThe Company sponsors a 401(k) Plan in the U.S. and other retirement plans (“the Plan”) in the rest of the world, all of which are defined contribution plans. The Plan is available to all employees who are age 21 or older. Participants may make voluntary contributions and the Company makes matching contributions according to the Plan’s matching formula. Matching contributions fully vest after one year of service for all employees. The expense related to the Plan primarily consists of the Company’s matching contributions.Expense related to the Plan totaled $9.8 million, $8.8 million and $6.5 million for the years ended December 31, 2024, 2023 and 2022, respectively.

17. OTHER INCOME (LOSS), NETThe following table summarizes other income (loss), net for the periods indicated: 

        For the Year Ended December 31,

        2024

        2023

        2022

        (in thousands)

        Accretion of investment discount, net
         
        $
        41,132

        $
        49,712

        $
        11,235

        Interest income

        30,635

        36,257

        16,488

        Interest expense

        (18,391
        )

        (22,010
        )

        (53,248
        )

        Change in fair value of derivatives*

        (7,838
        )

        (1,200
        )

        6,700

        Impairment of strategic investments

        —

        (30,321
        )

        (2,575
        )

        Other, net

        (2,845
        )

        617

        (6,921
        )

        Other income (expense), net
         
        $
        42,693

        $
        33,055

        $
        (28,321
        )

        Loss on debt extinguishment

        —

        (387,329
        )

        (125,441
        )

        Gain from sale of Priority Review Voucher

        —

        102,000

        —

        Total other income (loss), net